SCHEMBL2694591

SCHEMBL2694591

CC(C)S(=O)(=O)N1CCc2ccccc21

nearest known ligand 0.61

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.54
KMT2A Q03164 6/20 0.54
MEN1 O00255 5/20 0.54
ALDH1A1 P00352 4/20 0.54
TSHR P16473 3/20 0.54
MAPT P10636 2/20 0.54
POLB P06746 1/20 0.54
NPSR1 Q6W5P4 1/20 0.51
PDE4A P27815 1/20 0.49
PDE4B Q07343 1/20 0.49
PDE4C Q08493 1/20 0.49
PDE4D Q08499 1/20 0.49
PKM P14618 2/20 0.48
LMNA P02545 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4156875 0.82 KMT2A (0.63) KMT2AMEN1ALDH1A1TSHRMAPT
SCHEMBL28161168 0.81 MAPT (0.51) KMT2AMEN1ALDH1A1TSHRMAPT
SCHEMBL2102471 0.80 KMT2A (0.58) CYP11B1KMT2AMEN1ALDH1A1TSHR
SCHEMBL29035960 0.78 KMT2A (0.60) KMT2AMEN1ALDH1A1TSHRMAPT
SCHEMBL2881602 0.78 CYP11B1 (0.56) CYP11B1KMT2AMEN1MAPTPOLB
SCHEMBL3243743 0.78 CYP11B1 (0.56) CYP11B1KMT2AMEN1TSHRPOLB
SCHEMBL2694560 0.77 MEN1 (0.69) CYP11B1KMT2AMEN1ALDH1A1TSHR
SCHEMBL31254284 0.77 KMT2A (0.58) KMT2AMEN1ALDH1A1TSHRMAPT
SCHEMBL28647868 0.77 KMT2A (0.61) KMT2AMEN1ALDH1A1TSHRMAPT
SCHEMBL29638283 0.77 KMT2A (0.58) KMT2AMEN1ALDH1A1TSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8692001-B2 Sulfonamides for the modulation of PKM2 DYNAMIX PHARMACEUTICALS LTD. (IL) 2014-04-08 US disclosed
US-8692001-B2 Sulfonamides for the modulation of PKM2 DYNAMIX PHARMACEUTICALS LTD. (IL) 2014-04-08 US disclosed
EP-2632920-A1 SULFONAMIDES FOR THE MODULATION OF PKM2 Dynamix Pharmaceuticals Ltd. (IL) 2013-09-04 EP disclosed
WO-2012056319-A1 SULFONAMIDES FOR THE MODULATION OF PKM2 DYNAMIX PHARMACEUTICALS LTD. (IL) 2012-05-03 WO disclosed
WO-2012056319-A1 SULFONAMIDES FOR THE MODULATION OF PKM2 DYNAMIX PHARMACEUTICALS LTD. (IL) 2012-05-03 WO disclosed
US-20120108631-A1 Sulfonamides for the Modulation of PKM2 DYNAMIX PHARMACEUTICALS LTD. (IL) 2012-05-03 US disclosed
US-20120108631-A1 Sulfonamides for the Modulation of PKM2 DYNAMIX PHARMACEUTICALS LTD. (IL) 2012-05-03 US disclosed
US-20120108631-A1 Sulfonamides for the Modulation of PKM2 DYNAMIX PHARMACEUTICALS LTD. (IL) 2012-05-03 US disclosed
EP-2121657-A1 SULFONYLATED HETEROCYCLES USEFUL FOR MODULATION OF THE PROGESTERONE RECEPTOR Wyeth (US) 2009-11-25 EP disclosed
WO-2008109056-A1 SULFONYLATED HETEROCYCLES USEFUL FOR MODULATION OF THE PROGESTERONE RECEPTOR WYETH (US) 2008-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108631-A1 Sulfonamides for the Modulation of PKM2 PDK1, PDK4, PDK2 CYP11B1 2448/4885KMT2A 102/4885MEN1 4138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.